JP2002514082A - 二本鎖dnaと複素環オリゴマーの複合体形成 - Google Patents
二本鎖dnaと複素環オリゴマーの複合体形成Info
- Publication number
- JP2002514082A JP2002514082A JP54801098A JP54801098A JP2002514082A JP 2002514082 A JP2002514082 A JP 2002514082A JP 54801098 A JP54801098 A JP 54801098A JP 54801098 A JP54801098 A JP 54801098A JP 2002514082 A JP2002514082 A JP 2002514082A
- Authority
- JP
- Japan
- Prior art keywords
- oligomer
- stranded dna
- double
- heterocycle
- heterocycles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/853,522 | 1997-05-08 | ||
| US08/853,522 US6635417B1 (en) | 1996-07-31 | 1997-05-08 | Complex formation between DSDNA and oligomer of cyclic heterocycles |
| PCT/US1997/012722 WO1998050582A1 (en) | 1997-05-08 | 1997-07-21 | COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002514082A true JP2002514082A (ja) | 2002-05-14 |
| JP2002514082A5 JP2002514082A5 (cg-RX-API-DMAC10.html) | 2005-06-16 |
Family
ID=25316259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54801098A Ceased JP2002514082A (ja) | 1997-05-08 | 1997-07-21 | 二本鎖dnaと複素環オリゴマーの複合体形成 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6635417B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1007729A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002514082A (cg-RX-API-DMAC10.html) |
| AU (1) | AU746656B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2288806A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL132740A0 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998050582A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0973740A1 (en) * | 1996-02-26 | 2000-01-26 | California Institute Of Technology | Design, synthesis and use of specific polyamide dna-binding ligands |
| US6559125B1 (en) | 2000-01-28 | 2003-05-06 | California Institute Of Technology | Polyamide-alkylator conjugates and related products and method |
| US7078536B2 (en) | 2001-03-14 | 2006-07-18 | Genesoft Pharmaceuticals, Inc. | Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| ATE362940T1 (de) | 2000-03-16 | 2007-06-15 | Genesoft Inc | Geladene verbindungen mit einer nukleinsäure- bindenden einheit sowie deren verwendungen |
| GB0011938D0 (en) * | 2000-05-17 | 2000-07-05 | Angeletti P Ist Richerche Bio | Improvements relating to gene delivery systems |
| CA2450625A1 (en) | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Isoquinoline compounds having antiinfective activity |
| US6716866B2 (en) | 2001-06-13 | 2004-04-06 | Genesoft Pharmaceuticals, Inc. | Aryl-benzimidazole compounds having antiinfective activity |
| US6825228B2 (en) | 2001-06-13 | 2004-11-30 | Genesoft Pharmaceuticals, Inc. | Benzothiophene compounds having antiinfective activity |
| AU2002312370A1 (en) | 2001-06-13 | 2002-12-23 | Roland W. Burli | Antipathogenic benzamide compounds |
| AU2002368274A1 (en) * | 2001-09-13 | 2004-06-03 | Genesoft, Inc. | Methods of treating infection by drug resistant bacteria |
| CA2494139A1 (en) | 2002-08-02 | 2004-02-12 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
| AU2003285958A1 (en) | 2002-10-25 | 2004-05-25 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
| US7129214B2 (en) | 2002-12-10 | 2006-10-31 | Oscient Pharmaceuticals Corporation | Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| CA2531869A1 (en) * | 2003-04-30 | 2004-11-18 | Pharmacia Corporation | Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| US20060174364A1 (en) * | 2004-03-01 | 2006-08-03 | Avigenics, Inc. | Artificial chromosomes and transchromosomic avians |
| US20060019972A1 (en) * | 2004-04-27 | 2006-01-26 | California Institute Of Technology | Methods of treating cancer by inhibiting histone gene expression |
| US20060025429A1 (en) * | 2004-06-07 | 2006-02-02 | Dervan Peter B | Composition and methods for inhibiting expression of hypoxia-inducible genes |
| GB0619325D0 (en) * | 2006-09-30 | 2006-11-08 | Univ Strathclyde | New compounds |
| WO2008066890A2 (en) * | 2006-11-29 | 2008-06-05 | California Institute Of Technology | Polyamides with tail structures |
| US8835480B2 (en) * | 2007-04-23 | 2014-09-16 | California Institute Of Technology | Inhibitors for steroid response elements and related methods |
| US9630950B2 (en) | 2007-04-23 | 2017-04-25 | California Institute Of Technology | Inhibitors for steroid response elements and RNA polymerase II and related methods |
| WO2013033658A1 (en) | 2011-09-02 | 2013-03-07 | Northwestern University | Self-assembled nanostructures |
| AU2017321322A1 (en) | 2016-08-29 | 2019-02-28 | California Institute Of Technology | Compositions and methods for treatment of prostate cancer |
| JP7522726B2 (ja) | 2019-03-28 | 2024-07-25 | 株式会社カネカ | ピロールイミダゾール(ポリ)アミドの製造方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4795700A (en) * | 1985-01-25 | 1989-01-03 | California Institute Of Technology | Nucleic acid probes and methods of using same |
| GB8612218D0 (en) | 1986-05-20 | 1986-06-25 | Erba Farmitalia | Site specific alkylating agents |
| CA1308516C (en) * | 1987-07-06 | 1992-10-06 | The Governors Of The University Of Alberta | Oligopeptide anticancer and antiviral agents |
| GB8906709D0 (en) | 1989-03-23 | 1989-05-10 | Creighton Andrew M | Acryloyl substituted pyrrole derivatives |
| CA2005039A1 (en) | 1989-12-08 | 1991-06-08 | Randell L. Mills | Pharmaceuticals and apparatus providing diagnosis and selective tissue necrosis |
| US5459255A (en) * | 1990-01-11 | 1995-10-17 | Isis Pharmaceuticals, Inc. | N-2 substituted purines |
| AU1224392A (en) | 1991-02-06 | 1992-09-07 | Synphar Laboratories, Inc. | Oligopeptide antiretroviral agents |
| IT1247878B (it) | 1991-02-15 | 1995-01-05 | Menarini Farma Ind | Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono |
| US5578444A (en) | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
| US5726014A (en) | 1991-06-27 | 1998-03-10 | Genelabs Technologies, Inc. | Screening assay for the detection of DNA-binding molecules |
| JP3169610B2 (ja) | 1991-06-27 | 2001-05-28 | ジーンラブズ テクノロジーズ,インコーポレイテッド | Dna結合分子の検出のためのスクリーニングアッセイ |
| GB2261661A (en) | 1991-11-21 | 1993-05-26 | Erba Carlo Spa | Derivatives of poly-4-amino-2-carboxy-1-methyl pyrroles |
| US5273991A (en) | 1992-07-29 | 1993-12-28 | Research Corporation Technologies, Inc. | Imidazole-containing compositions and methods of use thereof analogs of distamycin |
| IT1271456B (it) | 1993-03-01 | 1997-05-28 | Menarini Farma Ind | Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono |
| IT1263089B (it) | 1993-04-26 | 1996-07-24 | Menarini Farma Ind | Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono. |
| WO1995004732A1 (en) * | 1993-08-06 | 1995-02-16 | Synphar Laboratories, Inc. | Oligopeptide antiretroviral agents |
| US5698674A (en) | 1994-04-13 | 1997-12-16 | The Regents Of The University Of California | Triheterocyclic peptides capable of binding the minor and major grooves of DNA |
| GB9416005D0 (en) | 1994-08-08 | 1994-09-28 | Erba Carlo Spa | Peptidic compounds analogous to distamycin a and process for their preparation |
| US5801155A (en) | 1995-04-03 | 1998-09-01 | Epoch Pharmaceuticals, Inc. | Covalently linked oligonucleotide minor grove binder conjugates |
| GB9514993D0 (en) | 1995-07-21 | 1995-09-20 | Pharmacia Spa | Site specific phenyl nitrogen mustards |
| EE9800230A (et) | 1996-02-01 | 1998-12-15 | Merck Frosst Canada & Co. / Merck Frosst Canada & Cie. | Difenüülstilbeenid kui COX-2 inhibiitorite eelravimid |
| US6143901A (en) * | 1996-07-31 | 2000-11-07 | Genesoft, Inc. | Complex formation between dsDNA and pyrrole imidazole polyamides |
| US6090947A (en) | 1996-02-26 | 2000-07-18 | California Institute Of Technology | Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
-
1997
- 1997-05-08 US US08/853,522 patent/US6635417B1/en not_active Expired - Lifetime
- 1997-07-21 WO PCT/US1997/012722 patent/WO1998050582A1/en not_active Ceased
- 1997-07-21 IL IL13274097A patent/IL132740A0/xx not_active IP Right Cessation
- 1997-07-21 CA CA002288806A patent/CA2288806A1/en not_active Abandoned
- 1997-07-21 EP EP97939339A patent/EP1007729A4/en not_active Withdrawn
- 1997-07-21 AU AU41450/97A patent/AU746656B2/en not_active Ceased
- 1997-07-21 JP JP54801098A patent/JP2002514082A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US6635417B1 (en) | 2003-10-21 |
| EP1007729A1 (en) | 2000-06-14 |
| EP1007729A4 (en) | 2006-05-17 |
| AU4145097A (en) | 1998-11-27 |
| WO1998050582A1 (en) | 1998-11-12 |
| AU746656B2 (en) | 2002-05-02 |
| IL132740A0 (en) | 2001-03-19 |
| CA2288806A1 (en) | 1998-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5998140A (en) | Complex formation between dsDNA and oligomer of cyclic heterocycles | |
| US6143901A (en) | Complex formation between dsDNA and pyrrole imidazole polyamides | |
| US6635417B1 (en) | Complex formation between DSDNA and oligomer of cyclic heterocycles | |
| CN1260006A (zh) | 双链dna和杂环低聚物之间复合物的形成 | |
| JP3231045B2 (ja) | 固体支持体上でのポリピロール及びポリイミダゾールカルボキサミドの合成方法 | |
| de la Torre et al. | Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences | |
| JP2002515063A (ja) | 予め決定されたdna配列にナノモル以下の濃度で結合するポリアミド | |
| JPH06506945A (ja) | ペプチド核酸 | |
| CN102557982A (zh) | 某些化学品、组合物及方法 | |
| TW202019442A (zh) | 用於反義遞送之三聚合肽 | |
| US7049061B1 (en) | Stereochemical control of the DNA binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove | |
| EP2069308B1 (en) | Azonafide derived tumor and cancer targeting compounds | |
| WO2014187314A1 (zh) | 一种药物靶标捕获方法 | |
| ES2351393T3 (es) | Sulfopirroles. | |
| US6559125B1 (en) | Polyamide-alkylator conjugates and related products and method | |
| US6673940B1 (en) | Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids | |
| WO2004099131A2 (en) | Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna | |
| EP1144414B1 (en) | Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids | |
| JP3725405B2 (ja) | テロメアなどに結合し得る分子、それを用いた方法 | |
| Sasaki et al. | Sequence‐Specific Alkylation by Y‐Shaped and Tandem Hairpin Pyrrole–Imidazole Polyamides | |
| US6288069B1 (en) | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue | |
| WO2026021549A1 (zh) | 一种肿瘤靶向型长非编码rna分子及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040720 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040924 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070313 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070315 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070507 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20071024 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071204 |